Scotland · NHS Scotland MSAN
Selegiline (Eldepryl®) 5mg and 10mg tablets
MSAN(2023)1 · Level 2 · issued 16 Jan 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Selegiline (Eldepryl®) 5mg and 10mg tablets are out of stock until April 2023. | Out of stock | April 2023 |
| 2. Rasagiline 1mg tablets remain available and can support a full uplift in demand. | Available | — |
| 3. Selegiline oral suspensions are available via specials manufacturers. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.